PH30746A - Chemical compounds. - Google Patents

Chemical compounds.

Info

Publication number
PH30746A
PH30746A PH45821A PH45821A PH30746A PH 30746 A PH30746 A PH 30746A PH 45821 A PH45821 A PH 45821A PH 45821 A PH45821 A PH 45821A PH 30746 A PH30746 A PH 30746A
Authority
PH
Philippines
Prior art keywords
pct
sec
carbon
organic group
date
Prior art date
Application number
PH45821A
Other languages
English (en)
Inventor
Klaveness Jo
Strande Per
Redford Keith
Solberg Jon
Original Assignee
Nycomed Imaging As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Imaging As filed Critical Nycomed Imaging As
Publication of PH30746A publication Critical patent/PH30746A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1818Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
    • A61K49/1821Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles
    • A61K49/1824Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles
    • A61K49/1827Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle
    • A61K49/1851Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with an organic macromolecular compound, i.e. oligomeric, polymeric, dendrimeric organic molecule
    • A61K49/1857Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with an organic macromolecular compound, i.e. oligomeric, polymeric, dendrimeric organic molecule the organic macromolecular compound being obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. PLGA
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/22Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
    • A61K49/222Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/223Microbubbles, hollow microspheres, free gas bubbles, gas microspheres

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Nanotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Acoustics & Sound (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Biological Depolymerization Polymers (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Peptides Or Proteins (AREA)
  • Polyamides (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PH45821A 1992-03-06 1993-03-08 Chemical compounds. PH30746A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929204918A GB9204918D0 (en) 1992-03-06 1992-03-06 Chemical compounds

Publications (1)

Publication Number Publication Date
PH30746A true PH30746A (en) 1997-10-17

Family

ID=10711636

Family Applications (1)

Application Number Title Priority Date Filing Date
PH45821A PH30746A (en) 1992-03-06 1993-03-08 Chemical compounds.

Country Status (30)

Country Link
US (1) US5574097A (lt)
EP (1) EP0629214B1 (lt)
JP (1) JP3281381B2 (lt)
CN (1) CN1038940C (lt)
AT (1) ATE144540T1 (lt)
AU (1) AU670069B2 (lt)
BG (1) BG99070A (lt)
BR (1) BR9306043A (lt)
CA (1) CA2130671A1 (lt)
CZ (1) CZ281738B6 (lt)
DE (1) DE69305628T2 (lt)
DK (1) DK0629214T3 (lt)
ES (1) ES2093413T3 (lt)
FI (1) FI944078A0 (lt)
GB (1) GB9204918D0 (lt)
GR (1) GR3022075T3 (lt)
HU (1) HUT69070A (lt)
IL (1) IL104962A (lt)
LT (2) LT3216B (lt)
LV (1) LV10294B (lt)
MD (2) MD940199A (lt)
NO (1) NO303123B1 (lt)
NZ (1) NZ249547A (lt)
OA (1) OA10097A (lt)
PH (1) PH30746A (lt)
PL (1) PL174125B1 (lt)
RU (1) RU2114865C1 (lt)
SK (1) SK105694A3 (lt)
WO (1) WO1993018070A1 (lt)
ZA (2) ZA931594B (lt)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020150539A1 (en) 1989-12-22 2002-10-17 Unger Evan C. Ultrasound imaging and treatment
GB9318288D0 (en) * 1993-09-03 1993-10-20 Nycomed Imaging As Improvements in or relating to contrast agents
US7083572B2 (en) 1993-11-30 2006-08-01 Bristol-Myers Squibb Medical Imaging, Inc. Therapeutic delivery systems
GB9417941D0 (en) * 1994-09-06 1994-10-26 Nycomed Imaging As Improvements in or relating to contrast agents
CA2164237A1 (en) * 1994-12-08 1996-06-09 Takeharu Tabuchi Acrylic monomer
TW503116B (en) * 1997-12-12 2002-09-21 Kimberly Clark Co Structure having balanced pH profile
US6309999B1 (en) * 1999-03-19 2001-10-30 Chandra P. Sharma Process for the preparation of an immunoadsorbent matrix
RU2175338C2 (ru) * 1999-05-05 2001-10-27 Дугуев Сергей Владимирович Способ получения органоминеральных пигментов
US6720445B2 (en) 2000-12-21 2004-04-13 Beacon Laboratories, Inc. Acetyloxymethyl esters and methods for using the same
US6818787B2 (en) 2001-06-11 2004-11-16 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
EP1902714B1 (en) 2001-06-11 2012-01-11 XenoPort, Inc. Prodrugs of gaba analogs, compositions and uses thereof
US8048917B2 (en) 2005-04-06 2011-11-01 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US7186855B2 (en) 2001-06-11 2007-03-06 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US7232924B2 (en) 2001-06-11 2007-06-19 Xenoport, Inc. Methods for synthesis of acyloxyalkyl derivatives of GABA analogs
AUPR951501A0 (en) * 2001-12-14 2002-01-24 Smart Drug Systems Inc Modified sustained release pharmaceutical system
ES2369640T3 (es) 2002-05-24 2011-12-02 Angiotech International Ag Composiciones y métodos para revestir implantes médicos.
US8313760B2 (en) 2002-05-24 2012-11-20 Angiotech International Ag Compositions and methods for coating medical implants
US20030235610A1 (en) * 2002-06-21 2003-12-25 Piedmont Pharmaceuticals, Llc Liposomes containing biologically active compounds
AU2004293075A1 (en) * 2003-11-20 2005-06-09 Angiotech International Ag Soft tissue implants and anti-scarring agents
CA2584338C (en) 2004-11-04 2013-08-06 Xenoport, Inc. Gabapentin prodrug sustained release oral dosage forms
AU2005100176A4 (en) * 2005-03-01 2005-04-07 Gym Tv Pty Ltd Garbage bin clip
JP2011505179A (ja) 2007-11-23 2011-02-24 テヒニーシェ ウニヴェルジテート ウィーン ポリビニルアルコールベースの生分解性、生体適合性、架橋ポリマーの調製用重合硬化性組成物
ES2485899T3 (es) * 2010-06-17 2014-08-14 Basf Se Polímeros con grupos laterales sacárido y su uso
RU2543895C2 (ru) * 2013-05-17 2015-03-10 Общество С Ограниченной Ответственностью "Научно-Производственный Центр "Амфион" Гидрогелевый материал на основе сшиваемого поливинилового спирта
JP7115914B2 (ja) 2017-06-23 2022-08-09 住友化学株式会社 レジスト組成物及びレジストパターンの製造方法
GB201810788D0 (en) * 2018-06-29 2018-08-15 Biocompatibles Uk Ltd Biodegradable polymer
RU2687231C1 (ru) * 2018-08-03 2019-05-08 Сергей Борисович Врублевский Способ получения пигментов
CN109928879A (zh) * 2019-03-05 2019-06-25 贵州大学 一种丙烯酸酯碳酸酯及其均聚物和共聚物材料
CN111892707B (zh) * 2020-06-18 2021-08-13 中山大学 一种阳离子聚酰胺材料及其制备方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4180646A (en) 1975-01-28 1979-12-25 Alza Corporation Novel orthoester polymers and orthocarbonate polymers
US4356166A (en) * 1978-12-08 1982-10-26 University Of Utah Time-release chemical delivery system
US4276885A (en) 1979-05-04 1981-07-07 Rasor Associates, Inc Ultrasonic image enhancement
US4718433A (en) 1983-01-27 1988-01-12 Feinstein Steven B Contrast agents for ultrasonic imaging
DE3463211D1 (en) 1983-07-01 1987-05-21 Battelle Memorial Institute Biodegradable polypeptide and its use in the sustained release of medicaments
US4741956A (en) * 1986-07-09 1988-05-03 Exxon Research And Engineering Company Biodegradable coatings of ionomer polymer
HU221485B (en) 1988-02-05 2002-10-28 Schering Ag Ultrasound contrast media consisting of microparticles and process for producing the same
GB9003821D0 (en) 1990-02-20 1990-04-18 Danbiosyst Uk Diagnostic aid
US5137928A (en) 1990-04-26 1992-08-11 Hoechst Aktiengesellschaft Ultrasonic contrast agents, processes for their preparation and the use thereof as diagnostic and therapeutic agents
AU636481B2 (en) 1990-05-18 1993-04-29 Bracco International B.V. Polymeric gas or air filled microballoons usable as suspensions in liquid carriers for ultrasonic echography
PH31064A (en) 1990-09-07 1998-02-05 Nycomed As Of Nycoveten Polymers containing diester units.

Also Published As

Publication number Publication date
GR3022075T3 (en) 1997-03-31
LTIP391A (en) 1994-09-25
ES2093413T3 (es) 1996-12-16
JPH07505177A (ja) 1995-06-08
NO943273L (no) 1994-09-05
CN1038940C (zh) 1998-07-01
EP0629214A1 (en) 1994-12-21
FI944078L (fi) 1994-09-05
NZ249547A (en) 1996-08-27
LV10294A (lv) 1994-10-20
IL104962A (en) 1996-01-31
PL174125B1 (pl) 1998-06-30
BG99070A (bg) 1995-08-28
LTIP388A (en) 1994-09-25
HUT69070A (en) 1995-08-28
ZA931594B (en) 1993-09-27
FI944078A7 (fi) 1994-09-05
WO1993018070A1 (en) 1993-09-16
AU3642393A (en) 1993-10-05
RU94045151A (ru) 1996-09-27
BR9306043A (pt) 1997-11-18
MD940206A (ro) 1996-01-31
DK0629214T3 (da) 1996-11-18
SK105694A3 (en) 1995-04-12
EP0629214B1 (en) 1996-10-23
LT3216B (en) 1995-04-25
OA10097A (en) 1996-12-18
GB9204918D0 (en) 1992-04-22
LV10294B (en) 1995-12-20
RU2114865C1 (ru) 1998-07-10
ZA931599B (en) 1993-12-28
DE69305628D1 (de) 1996-11-28
IL104962A0 (en) 1993-07-08
CA2130671A1 (en) 1993-09-07
CN1084524A (zh) 1994-03-30
CZ281738B6 (cs) 1997-01-15
FI944078A0 (fi) 1994-09-05
NO303123B1 (no) 1998-06-02
DE69305628T2 (de) 1997-03-06
ATE144540T1 (de) 1996-11-15
NO943273D0 (no) 1994-09-05
US5574097A (en) 1996-11-12
LT3199B (en) 1995-03-27
HU9402563D0 (en) 1994-11-28
JP3281381B2 (ja) 2002-05-13
CZ215294A3 (en) 1995-08-16
MD940199A (ro) 1996-01-31
AU670069B2 (en) 1996-07-04

Similar Documents

Publication Publication Date Title
HU9402563D0 (en) Chemical compounds
GR3019624T3 (en) Biodegradable polymers containing diester units
IL104963A (en) Contrast agents comprising methylene diester unit- containing biodegradable polymers
AUPO787897A0 (en) Silicon-containing chain extenders
IT1271325B (it) Composti diastereomericamente puri derivati da 3-oxo e 3-tioxo-4-azaandrostani e loro uso come antiandrogeni
TW363072B (en) Copolymers based on vinyl units and their use in electroluminescent devices
MX9705773A (es) Preparacion de poliuretanos que tienen curacion mejorada.
ES2092116T3 (es) Policarbonatos y sus usos para la preparacion de matrices bioerosionables.
AU1343388A (en) Iodinated polymers
AU7522398A (en) Sulfonyloxadiazolones
MX9705828A (es) Procedimiento para la polimerizacion de isocianatos.
TW223085B (en) Diaminophenoxyl naphthalene compounds and their polymers
YU18494A (sh) Tehnološki postupak dobijanja poliuretanskih elastomera namenjenih za zaštitu bilja i životne okoline